Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global PactThe Motley Fool • 10/27/20
What Are the Differences Between the Leading Coronavirus Vaccine Candidates?The Motley Fool • 10/25/20
What's the Timeline for FDA Emergency Use Authorization of Coronavirus Vaccines?The Motley Fool • 10/24/20
BioNTech to Present Data from BNT311 (GEN1046) and BNT131 (SAR441000) Programs at SITC 35th Annual MeetingGlobeNewsWire • 10/14/20
Will Covid-19 Vaccine Race Leaders Pfizer, BioNTech Post Initial Phase 3 Data This Week?Investors Business Daily • 10/14/20
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they standMarket Watch • 10/14/20
Here Are the Only 2 Coronavirus Vaccines That Could Meet the FDA's Authorization Guidelines by Year-EndThe Motley Fool • 10/14/20
Pfizer and BioNTech Coronavirus Vaccine Accepted for Rolling Review in CanadaThe Motley Fool • 10/12/20
BioNTech, Pfizer Sign Covid-19 Vaccine Deal With New Zealand; Seek Drug OK This YearInvestors Business Daily • 10/12/20